Protection of mouse heart against hypoxic damage by AMP deaminase inhibition

Nucleosides, Nucleotides and Nucleic Acids

Volumn 29, Issue 4-6, 2010, Pages 449-452

  Borkowski, T ^a   Slominska, E M ^a   Orlewska, C ^a   Chlopicki, S ^b   Siondalski, P ^a   Yacoub, M H ^c   Smolenski, R T ^a,c  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

AMP deaminase; heart; hypoxia; mouse

Indexed keywords

3 [2 (3 CARBOXY 4 BROMO 5,6,7,8 TETRAHYDRONAPHTHYL)ETHYL] 3,6,7,8 TETRAHYDROIMIDAZO[4,5 D][1,3]DIAZEPIN 8 OL; ADENOSINE MONOPHOSPHATE DEAMINASE; ADENOSINE MONOPHOSPHATE DEAMINASE INHIBITOR; APOLIPOPROTEIN E; ENZYME INHIBITOR; INOSINE PHOSPHATE; LOW DENSITY LIPOPROTEIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG INFUSION; ELECTROCARDIOGRAM; ENZYME INHIBITION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HYPOXIA; KNOCKOUT MOUSE; MOUSE; NONHUMAN; OXYGEN TENSION; ST SEGMENT;

AMP DEAMINASE; ANIMALS; ANOXIA; ENZYME INHIBITORS; MICE; MICE, KNOCKOUT;

MUS;

EID: 77953702032     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257771003741364     Document Type: Article

References (8)

1. Loh, E.; Rebbeck, T.R.; Mahoney, P.D.; DeNofrio, D.; Swain, J.L.H.; Holmes, E.W. Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure. Circ. 1999, 99, 1422-1425.
2. Anderson, J.L.; Habashi, J.; Carlquist, J.F.; Muhlestein, J.B.; Horne, B.D.; Bair, T.L.; Pearson, R.R.H.; Hart, N. A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease. J. Am. Coll. Cardiol. 2000, 36, 1248-1252.
3. Kasibhatla, S.R.; Bookser, B.C.; Xiao, W.H.; Erion, M.D. AMP deaminase inhibitors. 5. Design, synthesis, and SAR of a highly potent inhibitor series. J. Med. Chem. 2001, 44, 613-618.
4. Borkowski, T.; Orlewska, C.; Slominska, E.M.; Yuen, A.; Lipinski, M.; Rybakowska, I.; Foks, H.; Kaletha, K.K.; Yacoub, M.H.H.; Smolenski, R.T. Pharmacological inhibition of AMP-deaminase in rat cardiac myocytes. Nucleosides Nucleotides Nucleic Acids 2008, 27, 867-871.
5. Borkowski, T.; Slominska, E.M.; Orlewska, C.; Yuen, A.H.Y.; Al-Ayoubi, S.; Siondalski, P.; Yacoub, M.H.H.; Smolenski, R.T. Biological efficiency of AMP deaminase inhibitor: 3-[2-(3-carboxy- 4-bromo-5,6,7,8-tetrahydronaphthyl)ethyl] -3,6,7,8-tetrahydroimidazo[4,5]-[1,3]diazepin-8-ol. Nucleosides Nucleotides Nucleic Acids 2010 (this issue).
6. Caligiuri, G.; Levy, B.; Pernow, J.; Thoren, P.H.; Hansson, G.K. Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice. Proc. Natl. Acad. Sci. U. S. A 1999, 96, 6920-6924.
7. Hardie, D.G. AMP-activated protein kinase as a drug target. Annu. Rev. Pharmacol. Toxicol. 2007, 47, 185-210.
8. Smolenski, R.T.; Raisky, O.; Slominska, E.M.; Abunasra, H.; Kalsi, K.K.; Jayakumar, J.; Suzuki, K.H.; Yacoub, M.H. Protection from reperfusion injury after cardiac transplantation by inhibition of adenosine metabolism and nucleotide precursor supply. Circ. 2001, 104, I246-I252.